Vitamin D in cancer patients: Above all, do no harm

Journal of Clinical Oncology

Volumn 27, Issue 13, 2009, Pages 2117-2119

  Goodwin, Pamela J ^a  

^a MOUNT SINAI HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

1,25 VITAMIN D; CALCITRIOL; CALCIUM; ERGOCALCIFEROL; OXYGENASE; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG; VITAMIN D; VITAMIN D RECEPTOR; ZOLEDRONIC ACID; 25 HYDROXYVITAMIN D; 25-HYDROXYVITAMIN D; DRUG DERIVATIVE;

APOPTOSIS; BONE DEMINERALIZATION; BREAST CANCER; CANCER MORTALITY; CANCER PATIENT; CANCER RISK; CELL DIFFERENTIATION; CELL PROLIFERATION; CLINICAL TRIAL; COLORECTAL CANCER; DISEASE ASSOCIATION; DRUG MEGADOSE; DRUG SAFETY; EDITORIAL; HUMAN; HYPERCALCEMIA; HYPERVITAMINOSIS; NEPHROLITHIASIS; POSTMENOPAUSE; PRIORITY JOURNAL; RECOMMENDED DRUG DOSE; THERAPY EFFECT; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY; VITAMIN INTAKE; VITAMIN METABOLISM; VITAMIN SUPPLEMENTATION; BLOOD; BREAST TUMOR; DIET SUPPLEMENTATION; FEMALE; NOTE;

BREAST NEOPLASMS; DIETARY SUPPLEMENTS; FEMALE; HUMANS; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 65549088969     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2008.20.8629     Document Type: Editorial

References (24)

1. Crew KD, Shane E, Cremers S, et al: High prevalence of vitamin D deficiency despite supplementation in premenopausal women with breast cancer undergoing adjuvant chemotherapy. J Clin Oncol 13:2151-2156, 2009
2. Neuhouser ML, Sorensen B, Hollis BW, et al: Vitamin D insufficiency in a multiethnic cohort of breast cancer survivors. Am J Clin Nutr 88:133-139, 2008 (Pubitemid 351988692)
3. Goodwin PJ, Ennis M, Pritchard KI, et al: Vitamin D deficiency is common at breast cancer diagnosis and is associated with significantly higher risk of distant recurrence and death in a prospective cohort study of T1-3, N0-1, M0 breast cancer. J Clin Oncol 26:9s, 2008 (suppl; abstr 511)
4. Norman AW: From vitamin D to hormone D: Fundamentals of the vitamin D endocrine system essential for good health. Am J Clin Nutr 88:491S-499S, 2008
5. Beres S: Vitamin D: Cancer prevention's sunny future? J Natl Cancer Inst 100:292-297, 2008
6. Autier P, Gandini S: Vitamin D supplementation and total mortality: A meta-analysis of randomized controlled trials. Arch Intern Med 167:1730-1737, 2007 (Pubitemid 47403059)
7. Davis CD: Vitamin D and cancer: Current dilemmas and future research needs. Am J Clin Nutr 88:565S-569S, 2008
8. Giovannucci E, Liu Y, Rimm EB, et al: Prospective study of predictors of vitamin D status and cancer incidence and mortality in men. J Natl Cancer Inst 98:451-459, 2006
9. Rohan T: Epidemiological studies of vitamin D and breast cancer. Nutr Rev 65:S80-S83, 2007
10. Freedman DM, Looker AC, Chang SC, et al: Prospective study of serum vitamin D and cancer mortality in the United States. J Natl Cancer Inst 99:1594-1602, 2007
11. Wu K, Feskanich D, Fuchs CS, et al: A nested case control study of plasma 25-hydroxyvitamin D concentrations and risk of colorectal cancer. J Natl Cancer Inst 99:1120-1129, 2007 (Pubitemid 47241396)
12. Lappe JM, Travers-Gustafson D, Davies KM, et al: Vitamin D and calcium supplementation reduces cancer risk: Results of a randomized trial. Am J Clin Nutr 85:1586-1591, 2007 (Pubitemid 46890428)
13. Chlebowski RT, Johnson KC, Kooperberg C, et al: Calcium plus vitamin D supplementation and the risk of breast cancer. J Natl Cancer Inst 100:1581-1591, 2008
14. Ahn J, Peters U, Albanes D, et al: Serum vitamin D concentration and prostate cancer risk: A nested case-control study. J Natl Cancer Inst 100:796-804, 2008 (Pubitemid 351809669)
15. Chen W, Dawsey SM, Qiao YL, et al: Prospective study of serum 25(OH)-vitamin D concentration and risk of oesophageal and gastric cancers. Br J Cancer 97:123-128, 2007 (Pubitemid 47012092)
16. Greenwald P, Anderson D, Nelson SA, et al: Clinical trials of vitamin and mineral supplements for cancer prevention. Am J Clin Nutr 85:314S-317S, 2007 (Pubitemid 46067655)
17. Townsend K, Banwell CM, Guy M, et al: Autocrine metabolism of vitamin D in normal and malignant breast tissue. Clin Cancer Res 11:3579-3586, 2005 (Pubitemid 40627915)
18. Townsend K, Evans KN, Campbell MJ, et al: Biological actions of extra-renal 25-hydroxyvitamin D-1alpha-hydroxylase and implications for chemoprevention and treatment. J Steroid Biochem Mol Biol 97:103-109, 2005 (Pubitemid 41546219)
19. Chen WY, Bertone-Johnson ER, Hunter DJ, et al: Associations between polymorphisms in the vitamin D receptor and breast cancer risk. Cancer Epidemiol Biomarkers Prev 14:2335-2339, 2005 (Pubitemid 41437833)
20. Carlberg C: Current understanding of the function of the nuclear vitamin D receptor in response to its natural and synthetic ligands. Recent Results Cancer Res 164:29-42, 2003
21. Bischoff-Ferrari HA, Giovannucci E, Willett WC, et al: Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes. Am J Clin Nutr 84:18-28, 2006 (Pubitemid 44699167)
22. Holick MF. Vitamin D Status: Measurement, interpretation, and clinical application. Ann Epidemiol 19:73-78, 2009
23. Heaney RP: The Vitamin D requirement in health and disease. J Steroid Biochem Mol Biol 97:13-19, 2005
24. Holick MF: Vitamin D deficiency. N Engl J Med 357:266-281, 2007